<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948256</url>
  </required_header>
  <id_info>
    <org_study_id>H-18054954</org_study_id>
    <nct_id>NCT03948256</nct_id>
  </id_info>
  <brief_title>Danish RAndomized Trial of External Ventricular Drainage Cessation IN Aneurysmal Subarachnoid Haemorrhage</brief_title>
  <acronym>DRAIN</acronym>
  <official_title>Danish RAndomized Trial of External Ventricular Drainage Cessation IN Aneurysmal Subarachnoid Haemorrhage (DRAIN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the benefits and harms of two commonly used regimens for external ventricular
      drainage cessation in in patients with hydrocephalus following aneurysmal subarachnoid
      haemorrhage a randomized controlled setting.

      Design: Investigator-initiated, single-centre, 1:1 randomized, parallel group, outcome
      assessment blinded clinical trial of gradual weaning vs. prompt closure of external
      ventricular drainage in patients with hydrocephalus following aneurysmal SAH
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 6, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomization</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Due to the nature of the intervention with two arms with different time course it is not possible to mask patients nor investigators or care providers</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Any serious adverse events (SAE) including all-cause mortality</measure>
    <time_frame>6 months after admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SAE not including mortality</measure>
    <time_frame>6 months after admission</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Ventriculo-peritoneal shunt rate</measure>
    <time_frame>6 months after admission</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">244</enrollment>
  <condition>Aneurysmal Subarachnoid Hemorrhage</condition>
  <condition>Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>Control intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prompt closure, based on best available scientific data</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gradual weaning, based on best available scientific data</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control intervention</intervention_name>
    <description>Prompt closure of EVD with subsequent observation period</description>
    <arm_group_label>Control intervention</arm_group_label>
    <other_name>Prompt closure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Experimental intervention</intervention_name>
    <description>Gradual weaning of EVD with 5 cmH2O increase in drainage resistance daily until complete closure with subsequent observation period</description>
    <arm_group_label>Experimental intervention</arm_group_label>
    <other_name>Gradual weaning</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable or improving neurological status (GCS) during the last 24 hours

          -  No clinical or radiological signs of cerebral vasospasms as delayed neurological
             deficits (DND) during the last 24 hours

          -  Signed informed consent from patient or next-of-kin

        Exclusion Criteria:

          -  Severe pre-existing (physical or mental) disability or severe co-morbidity that would
             lead to poor outcome even if the patient made a full recovery from the aSAH.

          -  Life expectancy shorter than 48 hours based on clinical investigations

          -  Lack of signed informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tenna Capion, MD</last_name>
    <phone>(+45)22772588</phone>
    <email>tenna.baek.capion@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurosurgery</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tenna Capion, MD</last_name>
      <phone>(+45) 35450845</phone>
      <email>tenna.baek.capion@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Tiit Mathiesen, DMSc</last_name>
      <phone>(+45) 35453188</phone>
      <email>tiit.illimar.mathiesen@regionh.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>April 4, 2019</study_first_submitted>
  <study_first_submitted_qc>May 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2019</study_first_posted>
  <last_update_submitted>June 6, 2019</last_update_submitted>
  <last_update_submitted_qc>June 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Tiit Mathiesen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>External ventricular drain</keyword>
  <keyword>Weaning</keyword>
  <keyword>Closure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Hydrocephalus</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

